Coronary artery disease
Conditions
Interventions
None listed
Sponsors
Kansai Medical University Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Underwent elective coronary angiography or coronary intervention
Exclusion criteria
Exclusion criteria: patients with fever-up, acute and chronic infection, thyroid abnormality, collagen disease, using oral steroid therapy or using inhaled corticosteroid. a patient judged inappropriate by doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of HMGB1 and lipid plaque burden detected by integrated backscatter intravascular ultrasound (IB-IVUS) | — |
Secondary
| Measure | Time frame |
|---|---|
| i) Comparison of HMGB1 and instantaneous wave free ratio (iFR) or fractional flow reserve (FFR) in coronary angiography ii) Comparison of HMGB1 and % coronary stenosis calculated by quantitative coronary angiography (QCA) iii) Comparison of HMGB1 and slow flow phenomenon during coronary intervention iv) Comparison of HMGB1 and the grade of coronary collateral vessel v) Comparison of HMGB1 and the incidence of restenosis after coronary intervention vi) Comparison of HMGB1 and the incidence of composite endpoint of cardiac death, myocardial infarction, revascularization and stent thrombosis vii) Comparison of HMGB1 and inflammatory biomarkers of histone H3, syndical-1, lipoprotein(a) and oxidized lipoprotein(a), in addition relationship between these biomarkers and iFR, IB-IVUS and cardiovascular events viii) Comparison of HMGB1 and ankle brachial index (ABI) | — |
Countries
Japan
Contacts
Public ContactKoichiro Matsumura
Kansai Medical University Medical Center Department of Cardiology
Outcome results
None listed